AIkido Pharma Total Liabilities

AIkido Pharma (AIKI) currently reports a total liabilities of $54M as of March 2026. That compares with $9.9M in the prior-year period — up 442.5% year over year. Use the charts on this page to explore AIkido Pharma's total liabilities history and peer comparisons.

AIkido Pharma's total liabilities increased from $9.9M to $54M — a 442.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AIkido Pharma reported $54M in total liabilities as of March 2026. That compares with $9.9M in the prior-year period — up 442.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $54M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AIkido Pharma, and consider following AIKI for alerts when major investors trade the stock.

AIkido Pharma is classified in the Industrials sector. On total liabilities, it currently shows $54M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing AIKI with unrelated industries.